News Announcement

Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Investor Presentation

Submission of Investor Presentation on Unaudited Financial Results for Q1 of FY 2024-25.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.